Myeloproliferative Neoplasms: Genetic Mutations Beyond JAK

Watch Myeloproliferative Neoplasms: Genetic Mutations Beyond JAK featuring Dr. Abdulraheem Yacoub, an expert hematologist and oncologist who is certified by the American Board of Internal Medicine. Dr. Yacoub specializes in myeloproliferative disorders such as myelofibrosis. At the end of the event, the live Q&A answered all community submissions on myelofibrosis, clinical trials, genomic testing, and more. Myeloproliferative Neoplasms: Genetic Mutations Beyond JAK is hosted by Fiona Evans, Lead Patient Relations Coordinator at Massive Bio. Like the Massive Bio Facebook page to get notified about future events with our oncology experts. Submit the form on this page to watch the full event. Topics that were covered by include: 

• Myeloproliferative neoplasms (MPN) other than myelofibrosis 
• Mutations in MPNs such as myelofibrosis 
• How mutations are targeted in clinical trial therapies 
• Treatment options for MPNs with and without mutations 

Clinical trials test the latest scientific advancements in myelofibrosis treatment. Patients who choose to enroll in trials can receive cutting-edge treatment and high-quality care under the direction of scientists, doctors, and researchers. Myelofibrosis patients might gain access to promising drugs and innovative treatments long before they’re made available to the public.  

With Massive Bio’s AI technology, finding a clinical trial doesn’t have to be difficult or time consuming for patients or their physicians. Let us help you and your patients find the best trial within 48 hours of receipt of records. Myeloproliferative Neoplasms: Genetic Mutations Beyond JAK was live on Tuesday, February 9th at 5:00 pm EST. Fill out the form to watch the video of the event. Tune in to learn about myelofibrosis clinical trials, JAK mutations, how Massive Bio can help myelofibrosis patients, and more!